p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions

Hepato-Gastroenterology

Volumn 43, Issue 9, 1996, Pages 521-526

  Ajiki, T ^a   Onoyama, H ^a   Yamamoto, M ^a   Asaka, K ^a   Fujimori, T ^a   Maeda, S ^a   Saitoh, Y ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

DNA ploidy pattern; Dysplasia; Gallbladder cancer; p53; Prognosis

Indexed keywords

PROTEIN P53;

ADENOMA; ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER STAGING; CARCINOGENESIS; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; FEMALE; GALLBLADDER CANCER; GALLBLADDER CARCINOMA; GALLSTONE; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRECANCER; PRIORITY JOURNAL; PROGNOSIS;

ADENOMA, BILE DUCT; AGED; ANEUPLOIDY; BILE DUCT NEOPLASMS; DNA, NEOPLASM; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PRECANCEROUS CONDITIONS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029975601     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 1991; 351: 453-456.
2. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 1993; 329: 1318-1327.
3. Iggo R, Gatter K, Bartek J, Lane D, Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-679.
4. Lane DP: p53, guardian of the genome. Nature 1992; 358: 15-16.
5. Sun X-F, Carstensen JM, Zhang H, Stål O, Wingren S, Hatschek T, Nordenskjöd H: Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992; 340: 1369-1373.
6. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F: p53 expression and prognosis in gastric carcinoma. Int. J. Cancer 1992; 50: 859-862.
7. Stenmark-Askmalm M, Stål O, Sullivan S, Ferraud L, Sun X-F, Carstensen J, Nordenskjöd B: Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer. Eur. J. Cancer 1994; 30A: 175-180.
8. Ogura Y, Mizumoto R, Isaji S, Kusuda T, Matsuda S, Tabata M: Radical operations for carcinoma of the gallbladder: present status in Japan. World J. Surg. 1991; 15: 337-343.
9. Shirai Y, Yoshida K, Tsukada K, Muto T, Watanabe H: Radical surgery for gallbladder carcinoma. Ann. Surg. 1992; 216: 565-568.
10. Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y: p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J. Pathol. 1993; 170: 67-72.
11. Wee A, Teh M, Raju GC: Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions. J. Clin. Pathol. 1994; 47: 453-456.
12. Oohashi Y, Watanabe H, Ajioka Y, Hatakeyama K: p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder. Pathol. Int. 1995; 45: 58-65.
13. Nevin JE, Moran TJ, Kay S, King R: Carcinoma of the gallbladder: staging, treatment, and prognosis. Cancer 1976; 37: 141-148.
14. Koyama K, Goto H, Ouchi K, Sato T: Nuclear DNA pattern of the gallbladder. Tohoku J. Exp. Med. 1984; 143: 125-126.
15. Albores-Saavedra J, Henson DE: Tumors of the gallbladder and extrahepatic bile ducts. In Hartmann WH, Sobin L. H., eds. Atlas of Tumor Pathology, Second series, Fascicle 22. Washinton, The Armed Forces Institute of Pathology, 1984, 28-123
16. Dowling GP, Kelly JK: The histogenesis of adenocarcinoma of the gallbladder. Cancer 1986; 58: 1702-1708.
17. Yakawa M, Fujimori T, Maeda S, Tabuchi M, Nagasako K: Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut 1994; 35: 1258-1261.
18. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 1983; 31: 1333-1335.
19. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-481.
20. Sun X-F, Carstensen JM, Stål O, Zhang H, Nilsson E, Sjödahl R, Nordenskjöd B: Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma. Virchows Archiv. A Pathol. Anat. 1993; 423: 443-448.
21. Remvikos Y, Laurent-Puig P, Salmon RJ, Frelat G, Dutrillaux B, Thomas G: Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int. J. Cancer 1990; 45: 450-456.
22. Kaklamanis L, Gatter KC, Mortensen N, Baigrie RJ, Heryet A, Lane DP, Harris AL: p53 expression in colorectal adenomas. Am. J. Pathol. 1993; 142: 87-93.
23. Muto Y, Sho Y, Kurihara K, Yamada M, Yamauchi K, Uchimura M, Waki S: Morphological study of carcinoma of the gallbladder: its differences in between calculous and acalculous carcinoma. J. Jpn. Surg. Soc. 1985; 86: 846-852.
24. Teh M, Wee A, Raju GC: An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct / ampullary carcinomas. Cancer 1994; 74: 1542-1545.
25. Terada T, Shimizu K, Izumi R, Nakanuma Y: p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections. Modern Pathol 1994; 7: 249-252.
26. Bartek J, Iggo R, Gannon J, Lane DP: Genetic and immunohistochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990; 5: 893-899.